Active Pharmaceutical Ingredient (API)

Osimertinib Mesylate

EGFR Tyrosine Kinase Inhibitor

A third-generation, irreversible EGFR-TKI that targets both EGFR-sensitizing and EGFR T790M resistance mutations in non-small cell lung cancer (NSCLC).
Technical Profile
Reference Code
ONC1001
CAS Number
1421373-65-0
Chemical Class
N/A
Therapeutic Class
N/A

Verified Brands

Medicines containing Osimertinib Mesylate as an active ingredient.

Brand Name Manufacturer Formulation MRP
No verified brands found for this salt.